Phathom Pharmaceuticals Inc share price logo

Phathom Pharmaceuticals Inc

NASDAQ: PHAT

Small Cap

$12.36

-0.31

(-2.44%)

Live

as on

Phathom Pharmaceuticals Inc Stock Performance

as on May 8, 2026 at 1:07 am IST

  • Day's Low

    Day's High

    $12.32
    $12.74
    downward going graph

    0.32%

    Downside

    3.07%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $2.21
    $18.31
    downward going graph

    82.12%

    Downside

    48.14%

    Upside

    downward going graph

Phathom Pharmaceuticals Inc share price movements today

Previous Close
$12.67
Open
$12.62
Volume
51.1K
Day's Low - High
$12.32 - $12.74
52 Week Low - High
$2.21 - $18.31

Phathom Pharmaceuticals Inc Historical Returns

1 Month Return
+ 9.7 %
3 Month Return
+ 0.72 %
1 Year Return
+ 427.92 %
3 Year Return
+ 2.59 %
5 Year Return
-63.76 %

Phathom Pharmaceuticals Inc Stock Fundamentals & Key Indicators

Check Phathom Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.0B

EPS (TTM)

-0.0163

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-96.0M

Revenue (TTM)

204.9M

Profit Margin

-76.77%

Return On Equity TTM

-3489.00%

Phathom Pharmaceuticals Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Phathom Pharmaceuticals Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$1.0B-63.76%NA-76.77%
BUY$40.5B130.77%76.3212.55%
NA$32.5BNA70.895.37%
BUY$108.5B98.9%25.3835.51%
BUY$75.6B45.15%17.629.65%

Stock Returns calculator for Phathom Pharmaceuticals Inc Stock including INR - Dollar returns

The Phathom Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Phathom Pharmaceuticals Inc investment value today

Current value as on today

₹5,72,860

Returns

₹4,72,860

(+472.86%)

Returns from Phathom Pharmaceuticals Inc Stock

₹4,15,000 (+415%)

Dollar Impact

₹57,860 (+57.86%)

Analyst Recommendation on Phathom Pharmaceuticals Inc Stock

Based on 14 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 14 analysts, 85.71% of analysts recommend a 'BUY' rating for Phathom Pharmaceuticals Inc. Average target price of $23.7

Phathom Pharmaceuticals Inc Share Price Target

Get share price movements and forecasts by analysts on Phathom Pharmaceuticals Inc.

What analysts predicted

47.85%UPSIDE

Target Price

$23.7

Current Price

$12.36

Analyzed by

14 Analysts

Target

$23.70

Phathom Pharmaceuticals Inc target price $23.7, a slight upside of 47.85% compared to current price of $12.36. According to 14 analysts rating.

Indian Investors' Interest in Phathom Pharmaceuticals Inc Stock

Search interest for Phathom Pharmaceuticals Inc Stock has increased by 50% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:50% versus previous 30 day period

Phathom Pharmaceuticals Inc Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
0
1
7
16
29
28
39
49
57
58
Gross Profit
0
1
5
13
25
24
34
43
49
46
Operating Income
-69
-69
-77
-70
-59
-78
-59
-15
-5
-15
EBITDA
-66
-65
-73
-66
-55
-78
-59
-15
-5
-15
Interest Expense
13
17
17
18
18
18
17
16
16
15
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-79
-82
-91
-85
-74
-94
-75
-29
-21
-30
Income Tax Expense
-16
0
-
-
-
-
-
-
-
-
Net Income
-79
-82
-91
-85
-74
-94
-75
-29
-21
-30
Net Profit Margin
-11667.01%
-4333.26%
-1248.58%
-523.34%
-250.98%
-330.71%
-191.91%
-60.55%
-36.73%
-52.09%

Phathom Pharmaceuticals Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
0
55
175
Gross Profit
-
0
0
0
0
0
47
152
Operating Income
-1
-106
-125
-135
-172
-167
-277
-159
EBITDA
0
-250
-124
-136
-169
-159
-261
-159
Interest Expense
0
4
4
6
27
41
72
68
Depreciation
-
0
0
0
0
0
0
0
Income Before Tax
-1
-255
-129
-143
-197
-201
-334
-221
Income Tax Expense
0
-45
4
4
25
41
-
-
Net Income
-1
-209
-129
-143
-197
-201
-334
-221
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
-29558.94%
-605.09%
-126.35%

Phathom Pharmaceuticals Inc Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-82
-91
-85
-74
-94
-75
-29
-21
-30
Operating Cash Flow
-69
-70
-63
-63
-84
-62
-14
-5
-15
Investing Cash Flow
0
0
0
0
0
0
0
0
0
Financing Cash Flow
9
24
122
26
-
0
0
0
66
Change in Cash
-59
-45
58
-37
-84
-62
-14
-5
50

Phathom Pharmaceuticals Inc Annual Cash Flow

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-255
-129
-143
-197
-201
-334
-221
Operating Cash Flow
-36
-69
-148
-146
-137
-266
-166
Investing Cash Flow
-25
-1
0
-1
-1
0
0
Financing Cash Flow
304
114
44
120
367
182
0
Change in Cash
242
43
-104
-27
228
-84
-167

Global Institutional Holdings in Phathom Pharmaceuticals Inc

Funds
Holdings
Ensign Peak Advisors Inc
2.96%
Millennium Management LLC
2.62%
Citigroup Inc
0.73%
NEA Management Company, LLC
2.47%
State Street Corp
1.45%

Insights on Phathom Pharmaceuticals Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, PHAT stock has moved up by 13.1%

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, PHAT has outperformed top 5 stocks with highest market-cap in its industry

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 25.4% return, outperforming this stock by 22.8%

About Phathom Pharmaceuticals Inc

Phathom Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases in the United States. It develops VOQUEZNA, which has completed Phase III clinical trials for the treatment of erosive gastroesophageal reflux disease (GERD) and related heartburn in adults; and VOQUEZNA Triple Pak and VOQUEZNA Dual Pak that have completed Phase III clinical trials for treating Helicobacter pylori, as well as VOQUEZNA and vonoprazan for the treatment of heartburn associated with non-erosive GERD and eosinophilic esophagitis in adults and adolescents. The company was incorporated in 2018 and is headquartered in Florham Park, New Jersey.
OrganisationPhathom Pharmaceuticals Inc
Headquarters100 Campus Drive, Florham Park, NJ, United States, 07932
IndustryBiotechnology
CEOMr. Steven L. Basta M.B.A.
E-voting on sharesClick here to vote

Key Management of Phathom Pharmaceuticals Inc

Name

Title

Dr. Azmi Nabulsi M.D., M.P.H.

Co-Founder

Mr. Jonathan Bentley

Senior VP and Head of Sales, Operations & Training

Mr. Eric Sciorilli

Director of Business Development & Investor Relations

Mr. Bill Aprea J.D.

Senior VP, Chief Compliance Officer & Deputy Chief Legal Officer

Ms. Nancy R. Phelan

Senior Vice President of Marketing & Analytics

Mr. David A. Socks

Co-Founder

Mr. Sanjeev Narula

Chief Financial & Business Officer

Ms. Anne Marie Cook Esq., J.D.

Chief Legal Officer & Corporate Secretary

Mr. Robert Breedlove

VP of Finance & Principal Accounting Officer

Mr. Steven L. Basta M.B.A.

CEO, President & Director

FAQs

What is Phathom Pharmaceuticals Inc share price today?

Phathom Pharmaceuticals Inc share price today is $12.36 as on . Phathom Pharmaceuticals Inc share today touched a day high of $12.74 and a low of $12.32.

What is the 52 week high and 52 week low for Phathom Pharmaceuticals Inc share?

Phathom Pharmaceuticals Inc share touched a 52 week high of $18.31 on and a 52 week low of $2.21 on . Phathom Pharmaceuticals Inc stock price today i.e. is trending at $12.36,which is 32.50% down from its 52 week high and 459.28% up from its 52 week low.

What is Phathom Pharmaceuticals Inc's market capitalisation today?

Phathom Pharmaceuticals Inc market capitalisation is $0.00T as on .

How to invest in Phathom Pharmaceuticals Inc Stock (PHAT) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Phathom Pharmaceuticals Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Phathom Pharmaceuticals Inc Shares that will get you 0.1214 shares as per Phathom Pharmaceuticals Inc share price of $12.36 per share as on May 7, 2026 at 7:37 pm IST.

What is the minimum amount required to buy Phathom Pharmaceuticals Inc Stock (PHAT) from India?

Indian investors can start investing in Phathom Pharmaceuticals Inc (PHAT) shares with as little as ₹94.24 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹942.40 in Phathom Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Phathom Pharmaceuticals Inc share’s latest price of $12.36 as on May 7, 2026 at 7:37 pm IST, you will get 0.8091 shares of Phathom Pharmaceuticals Inc. Learn more about fractional shares .

What are the returns that Phathom Pharmaceuticals Inc has given to Indian investors in the last 5 years?

Phathom Pharmaceuticals Inc stock has given -63.76% share price returns and 29.81% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?